IdentificationGeneric Name(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-olDrugBank Accession NumberDB08463BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol (DB08463)× CloseWeightAverage: 431.5334 Monoisotopic: 431.243358585 Chemical FormulaC24H29N7OSynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUCyclin-dependent kinase 2Not AvailableHumansUCyclin-A2Not AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as phenylpyridines. These are polycyclic aromatic compounds containing a benzene ring linked to a pyridine ring through a CC or CN bond.KingdomOrganic compoundsSuper ClassOrganoheterocyclic compoundsClassPyridines and derivativesSub ClassPhenylpyridinesDirect ParentPhenylpyridinesAlternative Parents6-alkylaminopurines / Benzylamines / Secondary alkylarylamines / Aminopyrimidines and derivatives / N-substituted imidazoles / Imidolactams / Heteroaromatic compounds / Azacyclic compounds / Primary alcohols / Organopnictogen compounds / Hydrocarbon derivatives


 show 1 moreSubstituents2-phenylpyridine / 6-alkylaminopurine / 6-aminopurine / Alcohol / Amine / Aminopyrimidine / Aromatic heteropolycyclic compound / Azacycle / Azole / Benzenoid / Benzylamine / Heteroaromatic compound / Hydrocarbon derivative / Imidazole / Imidazopyrimidine / Imidolactam / Monocyclic benzene moiety / N-substituted imidazole / Organic nitrogen compound / Organic oxygen compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Primary alcohol / Purine / Pyrimidine / Secondary aliphatic/aromatic amine / Secondary amine


 show 18 moreMolecular FrameworkAromatic heteropolycyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyHOCBJBNQIQQQGT-LJQANCHMSA-NInChIInChI=1S/C24H29N7O/c1-4-19(14-32)28-24-29-22(21-23(30-24)31(15-27-21)16(2)3)26-13-17-8-10-18(11-9-17)20-7-5-6-12-25-20/h5-12,15-16,19,32H,4,13-14H2,1-3H3,(H2,26,28,29,30)/t19-/m1/s1IUPAC Name(2R)-2-{[9-(propan-2-yl)-6-({[4-(pyridin-2-yl)phenyl]methyl}amino)-9H-purin-2-yl]amino}butan-1-olSMILES[H][C@@](CC)(CO)NC1=NC2=C(N=CN2C(C)C)C(NCC2=CC=C(C=C2)C2=CC=CC=N2)=N1ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound10224714PubChem Substance99444934ChemSpider8400205BindingDB50154937ChEMBLCHEMBL518800ZINCZINC000016052807PDBe LigandRC8PDB Entries3ddp / 6td3Clinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.0177 mg/mLALOGPSlogP4.24ALOGPSlogP3.71ChemaxonlogS-4.4ALOGPSpKa (Strongest Acidic)14.32ChemaxonpKa (Strongest Basic)5.27ChemaxonPhysiological Charge0ChemaxonHydrogen Acceptor Count7ChemaxonHydrogen Donor Count3ChemaxonPolar Surface Area100.78 Å2ChemaxonRotatable Bond Count9ChemaxonRefractivity128.75 m3·mol-1ChemaxonPolarizability49.6 Å3ChemaxonNumber of Rings4ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleYesChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+1.0Blood Brain Barrier-0.5483Caco-2 permeable-0.5946P-glycoprotein substrateSubstrate0.8099P-glycoprotein inhibitor INon-inhibitor0.7468P-glycoprotein inhibitor IINon-inhibitor0.7758Renal organic cation transporterNon-inhibitor0.8122CYP450 2C9 substrateNon-substrate0.8161CYP450 2D6 substrateNon-substrate0.7947CYP450 3A4 substrateNon-substrate0.5572CYP450 1A2 substrateInhibitor0.8975CYP450 2C9 inhibitorInhibitor0.871CYP450 2D6 inhibitorInhibitor0.8524CYP450 2C19 inhibitorNon-inhibitor0.8765CYP450 3A4 inhibitorInhibitor0.5571CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.7816Ames testNon AMES toxic0.6432CarcinogenicityNon-carcinogens0.7992BiodegradationNot ready biodegradable0.9928Rat acute toxicity2.6113 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.8952hERG inhibition (predictor II)Inhibitor0.5057  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Cyclin-dependent kinase 2KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionMetal ion bindingSpecific FunctionSerine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, N...Gene NameCDK2Uniprot IDP24941Uniprot NameCyclin-dependent kinase 2Molecular Weight33929.215 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] 


 Details2. Cyclin-A2KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionNot AvailableSpecific FunctionEssential for the control of the cell cycle at the G1/S (start) and the G2/M (mitosis) transitions.Gene NameCCNA2Uniprot IDP20248Uniprot NameCyclin-A2Molecular Weight48550.365 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:32 / Updated at June 12, 2020 16:52 